Archana Shanker

Archana Shanker

Senior Partner and HOD Patents and Designs

Anand and Anand


B - 41, Nizamuddin East
New Delhi 110013


+91 120 4059300

E-mail Address:

Archana Shanker

Areas of Expertise

Patents, IP Litigation, Pharma & Biotech


Career Highlights: The force behind germination and growth of Patent Jurisprudence in India from a state of near dormancy, Archana Shanker is a senior partner at Anand and Anand where she leads its patent and design practice. She is a part of the advisory board for IAM’s first ever Women in Patents event.

Speaking of Archana, IAM says, “Archana Shanker’s ability to advise on patent matters of near infinite variety sets her apart as one of the best-rounded private practitioners. She has a faculty for complex prosecution and litigation, and has cultivated strategic wisdom having handled many matters of first impression in India”.

Thought Leadership: Behind her is dedicated practice of 29 years in prosecution, litigation, and opposition across industries. Drawing on her experience, she has penned the Halsbury's Laws of India chapter on patent besides being a contributor to several international publications.


Professional Involvement:

  • She is the first woman president of FICPI- India Section;
  • VP, North India for Licensing Executives Society International
  • Member of various international bodies like APAA and the AIPPI.

Recent awards/ accolades:

  • Expert Guides Women in Business Law -2016-2020
  • Recommended Individual – 2015 – 2020 (IAM 1000) and IAM 300 for 2020
  • Leaders League India Key Figure in Patent Litigation & Prosecution Practice
  • MIP - Top 250 Women IP Professionals, 2016-20 (MIP) & IP Starts Patent 2015-20
  • Spotlight for Life Sciences, India -2016 – 2020(Chambers and Partners)
  • Recognized for Patents and Life Sciences – 2015 – 2020 (WWL)
  • Asia Women in Business Law Award for 2019 - Euromoney Legal Media Group
  • Top 100 Powerful Women in Law, 2018(World IP Forum)


Can you protect your IP with an NDA?

Can you protect your IP w...

“Prevention is better than cure,” and it is always beneficia...

Success Story Turns Bleak for Compulsory License: A Report

Success Story Turns Bleak...

What are the compulsory license proceedings of Lee Pharma fo...


Please wait while the page is loading...